Aadi Bioscience (AADI) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Aadi Bioscience (AADI) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 3, 2023 (17:30)

Sector: Healthcare

The share price of Aadi Bioscience, Inc. (AADI) now

What analysts predict: $35.25
52-week High/Low: $17.27 / $6.8

50/200 Day Moving Average: $7.64 / $11.3

This figure corresponds to the Average Price over the previous 50/200 days. For Aadi Bioscience stocks, the 50-day moving average is the support level today.

For Aadi Bioscience stocks, the 200-day moving average is the resistance level today.

Are you interested in Aadi Bioscience, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aadi Bioscience stock price in 2023, 2024, 2025, 2026, 2027. How much will one Aadi Bioscience share be worth in 2023 - 2027?

When should I take profit in Aadi Bioscience stock? When should I record a loss on Aadi Bioscience stock? What are analysts' forecasts for Aadi Bioscience stock? What is the future of Aadi Bioscience stock? We forecast Aadi Bioscience stock performance using neural networks based on historical data on Aadi Bioscience stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aadi Bioscience stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aadi Bioscience shares. This happens once a day.


Sell or Buy Aadi Bioscience (AADI) stocks? Analytic Experts Forecasting...

We present you the most up-to-date and complete review of analytical trend forecasts and views on the AADI stock market. Experts share their opinions on what to expect from the … Read more



Historical and forecast chart of Aadi Bioscience stock

The chart below shows the historical price of Aadi Bioscience stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aadi Bioscience stock price can be found in the table below.

Long-term forecasts by years.

Aadi Bioscience daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 05 8.24 7.97 8.55 7.34
Jun 06 8.24 7.97 8.52 6.92
Jun 07 8.14 7.84 8.46 7.95
Jun 08 7.90 7.69 8.20 6.68
Jun 09 8.29 7.96 8.40 5.41
Jun 10 8.16 7.89 8.36 5.95
Jun 11 8.05 7.90 8.33 5.45
Jun 12 8.13 7.98 8.32 4.17
Jun 13 7.99 7.70 8.07 4.82
Jun 14 8.09 7.87 8.38 6.47
Jun 15 7.75 7.52 7.90 5.05
Jun 16 7.61 7.47 7.76 3.82
Jun 17 7.68 7.52 7.88 4.86
Jun 18 7.98 7.75 8.10 4.53
Jun 19 7.81 7.52 8.11 7.78
Jun 20 7.71 7.48 7.78 4.02
Jun 21 7.66 7.43 7.87 5.87
Jun 22 7.53 7.38 7.70 4.23
Jun 23 7.61 7.38 7.90 7.07
Jun 24 7.29 7.09 7.48 5.50
Jun 25 7.16 6.99 7.30 4.30
Jun 26 6.85 6.71 7.08 5.51
Jun 27 6.80 6.63 6.98 5.28
Jun 28 6.93 6.79 7.16 5.46
Jun 29 7.15 6.88 7.38 7.28
Jun 30 7.05 6.95 7.31 5.18
Jul 01 6.92 6.71 7.12 6.08
Jul 02 6.83 6.64 6.97 4.94
Jul 03 6.61 6.35 6.76 6.51
Jul 04 6.50 6.28 6.70 6.67

Aadi Bioscience Daily Price Targets


Aadi Bioscience Stock Forecast 06-05-2023.

Forecast target price for 06-05-2023: $8.24.
Positive dynamics for Aadi Bioscience shares will prevail with possible volatility of 6.840%.
Pessimistic target level: 7.97
Optimistic target level: 8.55

Aadi Bioscience Stock Forecast 06-06-2023.

Forecast target price for 06-06-2023: $8.24.
Negative dynamics for Aadi Bioscience shares will prevail with possible volatility of 6.474%.
Pessimistic target level: 7.97
Optimistic target level: 8.52

Aadi Bioscience Stock Forecast 06-07-2023.

Forecast target price for 06-07-2023: $8.14.
Negative dynamics for Aadi Bioscience shares will prevail with possible volatility of 7.363%.
Pessimistic target level: 7.84
Optimistic target level: 8.46

Aadi Bioscience Stock Forecast 06-08-2023.

Forecast target price for 06-08-2023: $7.90.
Negative dynamics for Aadi Bioscience shares will prevail with possible volatility of 6.259%.
Pessimistic target level: 7.69
Optimistic target level: 8.20

Aadi Bioscience Stock Forecast 06-09-2023.

Forecast target price for 06-09-2023: $8.29.
Positive dynamics for Aadi Bioscience shares will prevail with possible volatility of 5.136%.
Pessimistic target level: 7.96
Optimistic target level: 8.40

Aadi Bioscience Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $8.16.
Negative dynamics for Aadi Bioscience shares will prevail with possible volatility of 5.615%.
Pessimistic target level: 7.89
Optimistic target level: 8.36

AADI (AADI) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jun. 8.68 7.97 9.38 15.00
Jul. 8.89 7.54 9.85 23.47
Aug. 9.07 8.18 9.63 15.07
Sep. 9.47 8.75 10.81 19.09
Oct. 8.71 8.36 9.29 9.94
Nov. 8.26 7.76 9.15 15.16
Dec. 8.80 8.19 10.09 18.85

Aadi Bioscience forecast for this year


Aadi Bioscience Stock Prediction for Jun 2023

An uptrend is forecast for this month with an optimal target price of $8.68428. Pessimistic: $7.97. Optimistic: $9.38


Aadi Bioscience Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $8.8927. Pessimistic: $7.54. Optimistic: $9.85


Aadi Bioscience Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $9.07056. Pessimistic: $8.18. Optimistic: $9.63


Aadi Bioscience Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $9.46966. Pessimistic: $8.75. Optimistic: $10.81


Aadi Bioscience Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $8.71209. Pessimistic: $8.36. Optimistic: $9.29


Aadi Bioscience Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $8.25906. Pessimistic: $7.76. Optimistic: $9.15


Aadi Bioscience Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $8.80416. Pessimistic: $8.19. Optimistic: $10.09



Aadi Bioscience (AADI) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 8.24 6.94 8.70 20.27
Mar 8.60 7.31 9.53 23.29
Mar 9.77 8.31 11.30 26.47
Apr 9.52 8.43 10.59 20.32
May 9.98 8.68 11.45 24.22
Jun 9.16 8.68 10.39 16.40
Jul 9.36 8.12 10.30 21.09
Aug 10.01 9.03 10.82 16.48
Sep 9.13 8.29 9.50 12.69
Oct 9.97 9.28 10.71 13.41
Nov 11.33 9.59 12.49 23.23
Dec 10.90 10.16 11.44 11.24

Aadi Bioscience (AADI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 11.84 11.20 12.41 9.73
Mar 11.36 10.23 13.18 22.41
Mar 11.91 10.91 12.74 14.39
Apr 11.50 10.49 12.47 15.87
May 13.80 12.20 14.44 15.49
Jun 13.89 11.94 14.58 18.10
Jul 16.11 13.53 17.43 22.37
Aug 17.62 16.81 19.21 12.48
Sep 17.06 14.60 18.53 21.18
Oct 17.50 15.40 18.27 15.71
Nov 16.00 14.78 18.37 19.51
Dec 16.00 14.05 18.08 22.30

Aadi Bioscience (AADI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 17.47 16.63 18.41 9.68
Mar 19.43 16.86 22.42 24.78
Mar 22.22 19.42 24.98 22.24
Apr 24.36 22.12 28.06 21.18
May 24.70 23.22 28.65 18.97
Jun 27.12 22.78 28.20 19.23
Jul 32.43 27.50 34.71 20.75
Aug 29.52 27.21 31.23 12.85
Sep 27.04 23.68 30.77 23.02
Oct 24.71 23.53 25.85 8.99
Nov 23.18 20.12 25.68 21.66
Dec 23.74 20.70 27.01 23.37

Aadi Bioscience (AADI) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 24.73 23.05 27.75 16.93
Mar 27.11 22.88 29.65 22.85
Mar 30.79 28.82 33.69 14.44
Apr 33.69 29.11 38.81 25.00
May 33.96 29.61 39.05 24.17
Jun 37.15 34.10 41.31 17.45
Jul 34.10 30.83 38.81 20.56
Aug 40.17 34.79 44.03 20.99
Sep 37.36 33.10 39.75 16.73
Oct 34.22 32.17 35.80 10.13
Nov 32.65 30.10 35.85 16.03
Dec 31.47 27.00 36.26 25.52

Aadi Bioscience information and performance

Aadi Bioscience, Inc, formerly Aerpio Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing precision therapies for genetically defined cancers. It develops therapies for cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. Its lead product, FYARROTM, is an mTOR inhibitor bound to human albumin that has tumor accumulation, mTOR target suppression, and tumor growth inhibition over other mTOR inhibitors in preclinical models2. Its nab platform allows for intratumoral drug accumulation and mTOR target suppression (pS6) at equal doses for FYARROTM vs oral mTOR inhibitors resulting in higher anti-tumor activity in animal models. Its product, FYARROTM, is in phase II registrational trial for nab-sirolimus, ABI-009 in patients with advanced perivascular epithelioid cell tumors (PEComa).

Aadi Bioscience Address

9987 CARVER ROAD, CINCINNATI, OH, US

Market Capitalization: 189 142 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -61 899 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.47

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 1.543
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 12.63

Enterprise Value (EV) /Revenue

EV To EBITDA: -2.232

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 24437000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.